MEDIA RELEASE PR39054
Eularis Updates Reports That Help Pharmaceutical Companies Do More for Real Growth
Than Simply Downsizing
LONDON, April 8 /PRNewswire-AsiaNet/ --
New techniques and tools to provide actual growth for pharmacos showcased in
updated reports.
The pharmaceutical industry is facing unprecedented challenges on many fronts: a
slew of patient expiries, a lack of blockbusters in the pipeline to replace the
patent expiries, decreasing growth in many major markets, generic competition,
constantly changing regulatory and competitive environment rendering old tools for
analysis obsolete, increased pressure on CEOs to deliver shareholder growth resulting
in budget cuts, downsizing, and less than optimal results.
Therefore, given these challenges, today is the worst time in the history of
pharmaceuticals to be a pharmaceutical marketer.
Eularis has updated its reports that focus on specific key issues for pharma
marketers that help them understand how to handle these specific situations. These
reports uncover practices to predict how and where pharmaceutical marketing and sales
investments will yield the highest market share and market share price and highlight
real life case studies.
Readers will benefit from the step-by-step guidelines on successfully
implementing approaches for real and measurable results available only in these
reports.
Details about these updated reports can be found at:
www.ePharmaROI.com : How to Harness the Power of Social Media in Pharmaceutical
eMarketing.
Brand for Profit and Success
Strategy: Planning, Tactics and Implementation.
Using Analytics and Metrics to Improve the Bottom Line
You Measuring the Wrong Things?
(ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom
Line.
About Eularis:
that provide data-driven insight into the financial impact of corporate and marketing
decisions. Unlike traditional analytics approaches, whose reliance on historical or
analogue data reduces their accuracy, Eularis' proprietary 94.8 Analytics Process is
based on the current market situation. This proven approach helps pharmaceutical
marketing teams to quickly plan, measure, validate and optimize their sales and
marketing performance. Eularis has developed significant experience in the global
pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline,
Merck, Pfizer and others.
This release was issued on behalf of the above organization by Send2Press(R), a
SOURCE: Eularis
CONTACT: Dr. Kate Harwood of Eularis,
+44 2074035378,
KHarwood@eularis.com
NEWS 
